Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2016

View Archived Issues

AZD-7325, increases test stimulus intensity at 2-h post-dose in a phase I crossover study

Exploring optimal dosing of lonafarnib with ritonavir for the treatment of chronic delta hepatitis

DWN-10899, a novel Nav1.7 blocker significantly blocks neuropathic pain in mouse model

Sanford-Burnham Medical Research Institute patents APJ agonists

Janssen Pharmaceutica discloses TARPgamma8 modulators

Eli Lilly and Company describes BACE1 inhibitors

Chinese researchers develop antiviral agents

Sanford-Burnham Medical Research Institute presents EphA4 inhibitors

Gilead Sciences returns GS-4774 rights to GlobeImmune

Janssen submits application to FDA seeking approval of guselkumab

Agilis Biotherapeutics' AGIL-AADC wins FDA rare pediatric disease designation

FDA approves Intrarosa to treat dyspareunia in postmenopausal women

Endo's CCH significantly improves cellulite in phase II study

Resverlogix's apabetalone shows favorable PK profile in severe renal impairment

Cellectar Biosciences reports advances in Pierre Fabre research collaboration

ProMetic Life Sciences's PBI-4050 shows efficacy in phase II study in IPF

Celgene acquires marizomib assets from Triphase Accelerator

Novan reports promising preclinical data on SB-414 for psoriasis

Immune Pharmaceuticals secures new financing

Namodenoson approved as generic name for CF-102

Launch of International PSC Genome Project for primary sclerosing cholangitis

FDA awards fast track designation to Eisai's BACE inhibitor for Alzheimer's

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...